Heart failure can often be managed for many years with medicines, lifestyle changes, devices, and treatment of the underlying heart condition. But in some people, the heart becomes so weak or damaged that these treatments are no longer enough to control symptoms or maintain adequate circulation. This is known as advanced heart failure.
At this stage, a heart transplant may become one of the treatment options to consider. Understanding heart transplant surgery in the context of advanced heart failure involves more than looking at the heart's pumping function alone. Doctors consider symptoms, hospitalizations, response to treatment, other organs, overall health, and whether transplantation is likely to provide meaningful benefit.
What Is Advanced Heart Failure?
Advanced heart failure generally refers to a stage in which severe heart failure symptoms continue despite appropriate medical and device-based treatment, or the person becomes increasingly dependent on intensive therapies and hospital care.
People with advanced heart failure may experience:
- Shortness of breath with very little activity or even at rest
- Severe or persistent fatigue
- Difficulty performing everyday activities
- Repeated admissions to the hospital because of heart failure
- Fluid accumulation despite treatment
- Worsening kidney or liver function related to poor circulation
- Low blood pressure or other problems that limit heart-failure medicines
- Increasing dependence on intravenous medicines or other advanced support
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Not everyone with a low ejection fraction has advanced heart failure, and a person can have advanced heart failure even when the ejection fraction is not severely reduced. The overall clinical picture is therefore more important than one test result.
When Does a Heart Transplant Enter the Discussion?
A transplant is generally considered when the heart failure has become advanced enough that conventional treatment is no longer providing adequate control or an acceptable level of function and survival, while the person remains well enough to undergo the transplant evaluation process.
This timing is important. Waiting until a person is critically ill or has developed irreversible damage to other organs can make advanced therapies more difficult or unsafe.
For this reason, referral to an advanced heart failure and transplant team may be appropriate when there are signs that heart failure is progressing despite treatment, rather than waiting until all other options have been exhausted.
Signs That a Transplant Evaluation May Be Appropriate
There is no single symptom or test that automatically means someone needs a heart transplant. However, several developments can prompt doctors to consider an advanced heart failure evaluation.
Repeated heart failure hospitalizations
Frequent admissions despite appropriate treatment can indicate that the disease is becoming increasingly difficult to control.
Symptoms despite optimized treatment
Persistent breathlessness, fatigue, swelling, or severely reduced exercise capacity despite guideline-directed treatment may indicate advanced disease.
Increasing difficulty tolerating heart failure medicines
Some people develop low blood pressure, worsening kidney function, or other problems that prevent them from receiving or increasing medicines that would otherwise be useful.
Progressive organ dysfunction
Severe heart failure can reduce blood flow to other organs or cause venous congestion. Worsening kidney or liver function can therefore be an important warning sign, although the cause and reversibility of organ dysfunction need to be carefully assessed.
Dependence on advanced therapies
The need for intravenous medicines or mechanical circulatory support can indicate that the heart is struggling to maintain adequate circulation with standard treatment alone.
Does a Low Ejection Fraction Mean You Need a Heart Transplant?
No. Ejection fraction is an important measurement, but it does not by itself determine whether someone needs a transplant. Some people have a very low ejection fraction but remain stable for years with appropriate treatment. Others may develop severe symptoms and advanced heart failure despite having a less severely reduced ejection fraction.
The transplant team looks at the entire clinical picture, including symptoms, functional capacity, heart failure trajectory, exercise capacity, hemodynamics, kidney and liver function, nutritional status, previous treatments, and other medical conditions.
What Happens During a Heart Transplant Evaluation?
Being referred for a transplant evaluation does not mean that a transplant has already been decided upon. The purpose of the evaluation is to determine whether transplantation is appropriate and whether there are other advanced treatments that may be more suitable.
The assessment can involve several parts:
- Detailed cardiac assessment: Doctors review the cause and severity of heart failure and previous treatments.
- Imaging: Echocardiography and other cardiac imaging may be used to assess heart structure and function.
- Hemodynamic assessment: A right-heart catheterization may be performed to measure pressures and blood flow through the heart and lungs.
- Exercise or functional assessment: Tests may help determine how severely heart failure is limiting physical capacity.
- Blood and urine testing: Kidney, liver, blood-cell, metabolic, infectious, and other health parameters may be assessed.
- Assessment of other organs: Significant disease affecting the kidneys, liver, lungs, brain, or other organs can influence transplant suitability.
- Infection and cancer screening: The team evaluates conditions that could create additional risks after transplantation.
- Psychosocial and practical assessment: The team considers the person's ability to manage the demanding follow-up and medication requirements associated with transplantation.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Can a Heart Transplant Be the Only Option?
No. Advanced heart failure has several possible treatment pathways. The options can include continued medical and device-based treatment, mechanical circulatory support, heart transplantation, or a combination of approaches. The appropriate pathway depends on the person's disease, expected prognosis, other medical conditions, and individual goals.
Some patients may also receive palliative care alongside advanced heart failure treatment. Palliative care focuses on symptom relief, quality of life, and support for patients and families; it does not necessarily mean that disease-directed treatment has stopped.
Why Is Timing Important?
Heart transplantation requires major surgery followed by lifelong medical care. At the same time, delaying evaluation until a person becomes critically ill can create additional challenges.
Advanced heart failure guidance emphasizes referral while the disease is severe enough to justify consideration of advanced therapies but before irreversible end-organ damage or extreme clinical deterioration develops.
This is why a transplant evaluation can sometimes happen well before a person actually receives a donor heart. The evaluation gives the team time to understand the disease, identify potentially reversible problems, consider alternatives, and determine the safest treatment pathway.
What Happens If a Person Is Accepted for Transplant?
If the evaluation determines that transplantation is appropriate, the person may proceed through the transplant-listing and donor-matching process according to the applicable transplant system and clinical urgency.
While waiting, the medical team continues to manage heart failure and monitor the person's condition. Some patients remain stable enough to wait with medicines and other therapies, while others may require hospitalization or mechanical circulatory support.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
The condition can also change during the waiting period, which means the treatment plan may need to be adjusted over time.
The Bottom Line
Heart transplantation is an advanced treatment option for carefully selected people with advanced heart failure when conventional therapies are no longer providing adequate control. The decision is not based simply on ejection fraction or one symptom. Instead, transplant teams consider the severity and progression of heart failure, functional capacity, hospitalizations, response to treatment, other organs, overall health, and the potential risks and benefits of transplantation.
Importantly, being referred for a transplant evaluation does not automatically mean that a transplant will be performed. It is an opportunity for an advanced heart failure team to assess the available options, which may include continued medical treatment, mechanical circulatory support, transplantation, or other specialized therapies.
For people whose heart failure is progressing despite treatment, timely evaluation can help ensure that advanced treatment options are considered before the illness becomes too advanced for them to be safely offered.
